consortium to build quantum-enabled “brain-on-chip” platform for neurological drug discovery and screening
Chromos Labs, Tessara Therapeutics, Quantum Brilliance, Axol Biosciences, and the University of Melbourne today announced a consortium to develop a quantum-enabled brain-on-chip platform that measures…